---
figid: PMC9308561__pgac104fig5
pmcid: PMC9308561
image_filename: pgac104fig5.jpg
figure_link: /pmc/articles/PMC9308561/figure/fig5/
number: Figure 5
figure_title: ''
caption: 'Antitumor activity of our reengineered toxin in long-term experimental cancer
  therapies. (A)–(C). HT29 (BRAFV600E) (A), HT144 (BRAFV600E) (B), or HCT116 (KRASG13D)
  (C) tumor-bearing mice were treated (IP) with PBS or LF-W271A/IC3-PA twice a week
  as indicated by the red arrows. Tumor weights, mean ± SE. Right panels: Body weights,
  mean ± SD.'
article_title: A potent tumor-selective ERK pathway inactivator with high therapeutic
  index.
citation: Zehua Zuo, et al. PNAS Nexus. 2022 Jul;1(3):pgac104.
year: '2022'

doi: 10.1093/pnasnexus/pgac104
journal_title: PNAS Nexus
journal_nlm_ta: PNAS Nexus
publisher_name: Oxford University Press

keywords:
- anthrax lethal toxin
- CMG2
- ERK signaling
- intermolecular complementation
- tumor targeting

---
